R&D Alliance and Product Market Competition Among Alliance Partners
Eui-Kyo Jeong
Abstract
Eui-Kyo Jeong
Abstract
We examined the impact of R&D strategic alliances on the product market competition among alliance partners at a later date. Based on arguments of the resource-based view and knowledge transfer, we argue that R&D alliances facilitate more and smoother knowledge transfer among partners than other types of strategic alliances, which may help a firm launch a new product that is similar to those of (former) R&D alliance partners. Non-R&D alliances are more about a firm’s attempt to access knowledge owned or controlled by its alliance partners, whereas R&D alliances are more about integrating a piece of alliance partners’ knowledge with its existing stock of knowledge. Through such integration, this firm absorbs a piece of the alliance partners’ knowledge and may end up launching a similar product. The results show that biotechnology and pharmaceutical firms are more likely to introduce new drugs into therapeutic classes where their (former) R&D alliance partners have already had presence. The implication is that knowledge-based cooperation may end up increasing competition in the product market.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
We examined the impact of R&D strategic alliances on the product market competition among alliance partners at a later date. Based on arguments of the resource-based view and knowledge transfer, we argue that R&D alliances facilitate more and smoother knowledge transfer among partners than other types of strategic alliances, which may help a firm launch a new product that is similar to those of (former) R&D alliance partners. Non-R&D alliances are more about a firm’s attempt to access knowledge owned or controlled by its alliance partners, whereas R&D alliances are more about integrating a piece of alliance partners’ knowledge with its existing stock of knowledge. Through such integration, this firm absorbs a piece of the alliance partners’ knowledge and may end up launching a similar product. The results show that biotechnology and pharmaceutical firms are more likely to introduce new drugs into therapeutic classes where their (former) R&D alliance partners have already had presence. The implication is that knowledge-based cooperation may end up increasing competition in the product market.
Key concepts: Alliance, Business, Strategic alliance, Competition (biology), Industrial organization, Knowledge transfer, Product (mathematics), Product market